Several other brokerages also recently commented on CUTR. BidaskClub downgraded Cutera from a buy rating to a hold rating in a research report on Thursday, September 20th. Stephens dropped their price target on Cutera from $40.00 to $24.94 and set a sell rating on the stock in a research report on Friday. Stifel Nicolaus dropped their price target on Cutera from $55.00 to $45.00 and set a hold rating on the stock in a research report on Wednesday, August 8th. ValuEngine downgraded Cutera from a strong-buy rating to a buy rating in a research report on Wednesday, August 8th. Finally, Zacks Investment Research downgraded Cutera from a hold rating to a sell rating in a research report on Monday, August 13th. Two research analysts have rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating to the company. Cutera currently has a consensus rating of Hold and an average price target of $39.24.
Shares of NASDAQ CUTR opened at $21.44 on Friday. The company has a market capitalization of $450.39 million, a price-to-earnings ratio of 27.84 and a beta of 0.31. Cutera has a 12 month low of $20.75 and a 12 month high of $56.05.
In other news, insider James A. Reinstein acquired 1,000 shares of the stock in a transaction dated Wednesday, August 29th. The shares were acquired at an average cost of $32.02 per share, for a total transaction of $32,020.00. Following the completion of the transaction, the insider now owns 139,907 shares in the company, valued at approximately $4,479,822.14. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.80% of the company’s stock.
Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. United Services Automobile Association bought a new stake in shares of Cutera during the second quarter valued at approximately $208,000. Northern Trust Corp increased its position in shares of Cutera by 2.9% during the second quarter. Northern Trust Corp now owns 222,404 shares of the medical device company’s stock valued at $8,962,000 after purchasing an additional 6,249 shares during the period. Advisors Asset Management Inc. increased its position in shares of Cutera by 81.0% during the second quarter. Advisors Asset Management Inc. now owns 52,085 shares of the medical device company’s stock valued at $2,099,000 after purchasing an additional 23,315 shares during the period. Partner Fund Management L.P. increased its position in shares of Cutera by 21.6% during the second quarter. Partner Fund Management L.P. now owns 487,347 shares of the medical device company’s stock valued at $19,640,000 after purchasing an additional 86,621 shares during the period. Finally, Acuta Capital Partners LLC increased its position in shares of Cutera by 50.0% during the second quarter. Acuta Capital Partners LLC now owns 105,000 shares of the medical device company’s stock valued at $4,232,000 after purchasing an additional 35,000 shares during the period. Institutional investors and hedge funds own 93.36% of the company’s stock.
Cutera Company Profile
Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.
Further Reading: Average Daily Trade Volume – What It Means In Stock Trading
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.